Literature DB >> 7200770

Instability of (ara-C) DNA under alkaline conditions.

P P Major, E M Egan, D Herrick, D W Kufe.   

Abstract

We employed both [5-3H] ara-C and ([2-14C] ara-C labeled L1210 DNA for analysis following exposure to alkali under various conditions. The results demonstrated that the tritium label on C5 of ara-C molecules incorporated in DNA was exchanged with water under alkaline conditions and, therefore, radioactivity was subsequently detectable in the acid-soluble fraction. The [14C] ara-C labeled DNA, however, was not susceptible to loss or radioactivity by this mechanism, and the appearance of this isotope in the acid-soluble fraction required degradation of the DNA strand or pyrimidine ring. Our results indicated that the [14C] labeled DNA was degraded by alkali, suggesting structural instability of this abnormal nucleic acid. These findings provide useful technical information on the purification of (ara-C) DNA labeled with different isotopes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7200770     DOI: 10.1016/0006-2952(82)90475-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine.

Authors:  D D Ross; D P Cuddy; N Cohen; D R Hensley
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  A comparison of the effects of cytosine arabinoside and beta-lactams on DNA synthesis and cellular proliferation.

Authors:  R J Fram
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

3.  DNA Methyltransferases Demonstrate Reduced Activity against Arabinosylcytosine: Implications for Epigenetic Instability in Acute Myeloid Leukemia.

Authors:  Christopher S Nabel; Jamie E DeNizio; Martin Carroll; Rahul M Kohli
Journal:  Biochemistry       Date:  2017-04-12       Impact factor: 3.162

4.  Chemical synthesis of DNA oligomers containing cytosine arabinoside.

Authors:  G P Beardsley; T Mikita; M M Klaus; A L Nussbaum
Journal:  Nucleic Acids Res       Date:  1988-10-11       Impact factor: 16.971

5.  A phase I-II study of combination therapy with thymidine and cytosine arabinoside.

Authors:  R Fram; P Major; E Egan; P Beardsley; D Rosenthal; D Kufe
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.